Produkty 118555-82-1

CAS 118555-82-1 występuje w naszej ofercie pod nazwami: Phaseoloidin, Phaseoloidin/ 98%, 2-(5-Hydroxy-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)acetic acid, 95%, 95%, Phaseoloidin, 99.92%. Oferty producentów: GLPBio, TargetMol, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 5mg, 1mg, 10mg, 25mg, 50mg, 100mg, 500mg, 10 mg.

Phaseoloidin
GLPBio, Biosynth
  • opakowanie: 5mg, 50mg, 25mg, 100mg
  • Warianty: 4
od 919,99
Zobacz produkt
Phaseoloidin/ 98%
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 7
od 445,96
Zobacz produkt
2-(5-Hydroxy-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)acetic acid, 95%, 95%
Chemat
  • opakowanie: 1mg, 5mg, 25mg
  • Warianty: 3
od 318,80
Zobacz produkt
Phaseoloidin, 99.92%
MedChemExpress
  • opakowanie: 10 mg, 5 mg, 1 mg
  • Warianty: 3
od 394,00
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

2-[5-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]acetic acid (CAS 118555-82-1) to związek chemiczny o wzorze sumarycznym C14H18O9 i masie molowej 330.29 g/mol. Nazwa systematyczna IUPAC: 2-[5-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]acetic acid. InChIKey: MVFYXXNAFZRZAM-RGCYKPLRSA-N.

Dane identyfikacyjne
Wzór sumarycznyC14H18O9
Masa molowa330.29 g/mol
Nazwa IUPAC2-[5-hydroxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]acetic acid
InChIKeyMVFYXXNAFZRZAM-RGCYKPLRSA-N
SMILESC1=CC(=C(C=C1O)CC(=O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: PHASEOLOIDIN, orb1220789, orb1301500, 2-glucopyranosyloxy-5-hydroxyphenyl acetic acid, [2-(beta-D-Glucopyranosyloxy)-5-hydroxyphenyl]acetic acid
Izomery (ten sam wzór sumaryczny)
[(2R,3R,4S)-3,4,5-triacetyloxy-3,4-dihydro-2H-pyran-2-yl]methyl acetate C14H18O9
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[2-hydroxy-5-(2-hydroxyethyl)phenoxy]oxane-2-carboxylic acid C14H18O9
3-methoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoic acid C14H18O9
methyl 2-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate C14H18O9
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 2-hydroxy-3-methoxybenzoate C14H18O9
1-[2,3-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethanone C14H18O9
1-[2,6-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethanone C14H18O9
1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethanone C14H18O9
methyl 4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate C14H18O9
3-methoxy-4-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoic acid C14H18O9
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 4-hydroxy-3-methoxybenzoate C14H18O9